Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Pleural Effusion, Malignant 2 Lung Neoplasms 2 Pleural Effusion 1 Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Thoracoscopy 4 vandetanib 2 Povidone-Iodine 2 Cisplatin 2 dalotuzumab 1 X-Rays 1 Ultrasonography 1 Tyrosine Kinase Inhibitors 1 Tissue Plasminogen Activator 1 Thoracentesis 1 Tenecteplase 1 Surgical Procedures, Operative 1 Saline Solution 1 Receptors, Vascular Endothelial Growth Factor 1 Pleurodesis 1 Pemetrexed 1 Octreotide 1 Naproxen 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gemcitabine 1 Fentanyl 1 Diclofenac 1 Deoxyribonucleases 1 Dasatinib 1 Darbepoetin alfa 1 Clinical Laboratory Techniques 1 Chest Tubes 1 Cdc25C phosphatase (211-221) 1 Catheters, Indwelling 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pleural Effusion × Thoracentesis × Clear all

NCT01141946 2012-07-17

CT0018

Centre hospitalier de l'Université de Montréal (CHUM)

Lung Neoplasms, Pleural Effusion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡